top of page
gradientForSurfBreak.png

Item List

Yahoo
Invitae and Simons Searchlight Partner to Accelerate Research through Data Sharing

Invitae (NYSE: NVTA), a leading medical genetics company, today announced a collaboration with Simons Searchlight, an international research program with a goal of accelerating research and improving lives for people with rare genetic neurodevelopmental disorders. This partnership will connect two sets of data – the longitudinal clinical data extracted from medical records through Invitae's Ciitizen, a patient-consented, digital natural history data platform and patient reported outcomes and biospecimens collected by Simons Searchlight. The partnership breaks down data silos and provides a rich and deep dataset that will help accelerate research for rare neurodevelopmental diseases.

Recent Posts

Portfolio Company

Carlsmed.png

AI Used for Skin Cancer Checks at London Hospital
...

BBC

Portfolio Company

Carlsmed.png

CARTI Cancer Center Deploys DeepScribe's Ambient Operating System for Oncology ...

PR Newswire

Portfolio Company

Carlsmed.png

Ideem locks in $2.4M seed round for trust tech spinout driven by Toby Rush, star ...

Startland News

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page